Drug Profile
Research programme: women's health therapeutics - Avion Pharmaceuticals
Alternative Names: Captisol®-enabled therapeutics - Avion Pharmaceuticals; Cyclodextrin-enabled therapeutics - Avion PharmaceuticalsLatest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator Avion Pharmaceuticals
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Female genital diseases
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for research development in Gynaecological-disorders in USA (PO)
- 28 Sep 2018 No recent reports of development identified for research development in Gynaecological-disorders in USA (Topical)
- 15 Aug 2014 Early research in Gynaecological disorders in USA (Topical)